![Sang-Woo Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sang-Woo Lee is currently a Director at Geneos Therapeutics, Inc. since 2021.
Formerly, Mr. Lee was a Director at Korea Investment Partners Co., Ltd. from 2014 to 2016.
| Sociétés | Poste | Début |
|---|---|---|
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Directeur/Membre du Conseil | 03/03/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Korea Investment Partners Co., Ltd.
 Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners invests in companies located in South Korea. The firm focuses on biotech & healthcare, interactive contents & media, consumer internet & fintech, ICT & digitalization, and semiconductor & industrial sectors. It provides financing for early and growth capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Korea Investment Partners Co., Ltd.
Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners invests in companies located in South Korea. The firm focuses on biotech & healthcare, interactive contents & media, consumer internet & fintech, ICT & digitalization, and semiconductor & industrial sectors. It provides financing for early and growth capital requirements. | Finance |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
